Repligen | RGEN - 自己資本および準備金





自己資本および準備金 変化する 日付
Agilent USD 7.12B 214M 2026-03
Align Technology USD 4.15B 100.27M 2026-03
Bio Techne USD 2.09B 74.32M 2026-03
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Bruker USD 2.46B 35.9M 2025-12
Charles River Laboratories USD 2.9B 265.94M 2026-03
Danaher USD 52.58B 368M 2026-06
Dentsply International USD 1.32B 21M 2026-03
General Electric Aerospace USD 17.64B 417M 2026-06
Henry Schein USD 3.27B 21M 2026-03
Illumina USD 2.84B 162M 2026-06
IQVIA Holdings USD 6.17B 50M 2026-06
Mettler Toledo International USD 12.82M 54.71M 2026-06
Myriad Genetics USD 303.9M 33.5M 2026-06
OraSure Technologies USD 313.32M 27.5M 2026-03
Pacific Biosciences Of California USD 2.37M 2.98M 2026-03
Pfizer USD 90.1B 3.63B 2026-03
Repligen USD 2.11B 6.57M 2026-06
Revvity USD 7.25B 125.54M 2025-12
Standard Biotools USD 561.12M 136.83M 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Waters USD 2.56B 230.55M 2025-12
West Pharmaceutical Services USD 2.99B 200K 2026-06